Dr. Sulochana Manandhar
About me
I am a highly motivated molecular microbiologist and postdoctoral researcher with extensive experience in infectious diseases and antimicrobial resistance. My work focuses on evidence-based, innovative research addressing locally relevant health priorities with global impact. I have a strong record of high-impact publications, expertise in advanced molecular techniques, and proven experience leading multi-site clinical studies in collaboration with local and international partners.
I am a highly motivated molecular microbiologist and postdoctoral researcher with extensive experience and a core research focus on infectious diseases and antimicrobial resistance. I am committed to advancing scientific knowledge through rigorous, evidence-based, and innovative research that addresses locally relevant health priorities while contributing to discoveries of global significance. My record of high-impact publications reflects a strong commitment to addressing critical scientific and public health challenges. I bring expertise in advanced molecular and microbiological techniques, along with substantial experience in the successful design and implementation of multi-site clinical studies in collaboration with key local and international stakeholders. These strengths underpin my ambition to make meaningful and sustained contributions to scientific research.
Degrees:
caused by mcr-10 carrying Enterobacterkobei in a tertiary care hospital in Nepal.
Journal of Hospital Infection. J Hosp Infect. 2022 Jul;125:60-66. doi:
10.1016/j.jhin.2022.03.015. Epub 2022 Apr 20.
antimicrobial resistance, and virulence factors of Enterobacter cloacae complex
causing potential community-onset bloodstream infections in a tertiary care hospital
of Nepal. JAC Antimicrob Resist. 2022 May 30;4(3):dlac050. doi:
10.1093/jacamr/dlac050
resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated
widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and
carbapenemase-encoding genes. Ann ClinMicrobiolAntimicrob. 2020 Oct
21;19(1):48. doi: 10.1186/s12941-020-00390-y.
SM, Baker S, Karkey A. Risk factors for the development of neonatal sepsis in a
neonatal intensive care unit of a tertiary care hospital of Nepal. BMC Infect Dis. 2021 Jun 9;21(1):546. doi: 10.1186/s12879-021- 06261-x. PMID: 34107906; PMCID:
PMC8191200
on an inappropriate use of antimicrobials in Kathmandu, Nepal. PLoS One.
2023;18:1–14: e0285287. https://doi.org/10.1371/journal.pone.0285287 (*Equally
contributing first author)
https://orcid.org/0000-0003-1478307X